leukemia

As nouns the difference between leukemia and leukemid

is that leukemia is leukemia (cancer of blood forming tissue) while leukemid is a non-specific skin lesion that occurs with leukemia but is not related to leukemic cell infiltration.

As nouns the difference between taxonomy and leukemia

is that taxonomy is the science or the technique used to make a classification while leukemia is leukemia (cancer of blood forming tissue).

As nouns the difference between leukemia and thalassemia

is that leukemia is a type of malignancy affecting the blood cells or blood-forming tissues while thalassemia is any of a group of inherited disorders in which the amount of hemoglobin in the blood is reduced.

As a noun leukemia

is a type of malignancy affecting the blood cells or blood-forming tissues.

As an adjective leukemogenic is

that tends to cause leukemia.

As a noun leukemia

is leukemia (cancer of blood forming tissue).

As an adjective erythroleukemic is

of or pertaining to erythroid leukemia.

As nouns the difference between leukemia and ubenimex

is that leukemia is leukemia (cancer of blood forming tissue) while ubenimex is a particular protease inhibitor used in the treatment of some leukemias.

As nouns the difference between leukemia and lumiliximab

is that leukemia is leukemia (cancer of blood forming tissue) while lumiliximab is a chimeric monoclonal antibody being investigated for the treatment of chronic lymphocytic leukemia.

As nouns the difference between leukemia and rituximab

is that leukemia is leukemia (cancer of blood forming tissue) while rituximab is a chimeric monoclonal antibody against the protein cd20, used in the treatment of lymphomas, leukemias, and some autoimmune disorders.

As nouns the difference between leukemia and antileukemic

is that leukemia is leukemia (cancer of blood forming tissue) while antileukemic is any drug that prevents or counters leukemia.

As an adjective antileukemic is

preventing or countering leukemia.

As nouns the difference between leukemia and ofatumumab

is that leukemia is leukemia (cancer of blood forming tissue) while ofatumumab is a human monoclonal antibody under investigation for the treatment of chronic lymphocytic leukemia and other diseases.